| Sirona Dental Systems Prices 7.25mm Secondary Share Offering |
| LONG ISLAND CITY, N.Y., Feb 17, 2010 (BUSINESS WIRE) -- Sirona Dental Systems, Inc. ("Sirona") (Nasdaq: SIRO) today announced
the pricing of the previously announced public offering by Sirona
Holdings Luxco S.C.A. of 7,000,000 shares of common stock and 250,000
shares by Jeffrey T. Slovin, at a price to the public of $35.35 per
share. The offering is expected to close on February 22, 2010 subject to
customary closing conditions. Sirona Dental Systems, Inc. will not
receive any proceeds from this sale of its common stock. One of the
selling stockholders, Sirona Holdings Luxco S.C.A., has also granted the
underwriter a 30-day option to purchase up to 1,050,000 additional
shares of common stock.
Barclays Capital Inc. is the sole underwriter of the offering. The offering will be made only by means of a prospectus supplement and accompanying base prospectus, copies of which may be obtained from: Barclays Capital Inc., c/o Broadridge, Integrated Distribution Services, 1155 Long Island Avenue, Edgewood, New York 11717; Barclaysprospectus@broadridge.com (phone: 888-603-5847). A copy of the prospectus supplement and accompanying base prospectus may also be obtained at no charge at the U.S. Securities and Exchange Commission's website, at http://www.sec.gov. The shelf registration statement relating to the foregoing has previously been filed with, and declared effective by the U.S. Securities and Exchange Commission. This press release does not constitute an offer to sell or a solicitation of an offer to buy the shares of Sirona's common stock or any other securities, nor will there be any sale of the shares of Sirona's common stock or any other securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction. About Sirona Dental Systems, Inc. Sirona has served dealers and dentists worldwide for more than 130 years. Sirona develops, manufactures, and markets a complete line of dental products, including CAD/CAM restoration systems (CEREC), digital intra-oral, panoramic and 3D imaging systems, dental treatment centers and handpieces. Contact John Sweeney, CFA, Vice President, Investor Relations, at 718-482-2184 or john.sweeney@sirona.com for more information about Sirona and its products. This press release and any attachment thereto contains forward-looking information about Sirona Dental Systems, Inc.'s financial results, guidance and estimates, business prospects, and products and services that involve substantial risks and uncertainties or other factors that may cause actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. You can identify these statements by the use of words such as "may," "could," "estimate," "will," "believe," "anticipate," "think," "intend," "expect," "project," "plan," "target," "forecast", and similar words and expressions which identify forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements are not guarantees of future performance and involve known and unknown risks and uncertainties, and other factors. Readers are cautioned not to place undue reliance on such statements, which speak only as of the date hereof. For a discussion of such risks, uncertainties and other matters that could cause actual results to differ materially, including risks relating to, among other factors, the market for dental product and services, pricing, future sales volume of the Company's products, the possibility of changing economic, market and competitive conditions, dependence on products, dependence on key personnel, technological developments, intense competition, market uncertainties, dependence on distributors, ability to manage growth, dependence on key suppliers, dependence on key members of management, government regulation, acquisitions and affiliations, readers are urged to carefully review and consider various disclosures made by the Company in its Annual Report on Form 10-K and in its reports on Forms 10-Q and 8-K filed with the U.S. Securities and Exchange Commission. The Company assumes no obligation to update any forward-looking statements contained in this document or the attachments to reflect new information or future events or developments after the date any such statement is made. SOURCE: Sirona Dental Systems, Inc. Sirona Dental Systems, Inc. |